These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 16757558)

  • 41. Antibodies to a synthetic peptide from the preS 120-145 region of the hepatitis B virus envelope are virus neutralizing.
    Neurath AR; Kent SB; Parker K; Prince AM; Strick N; Brotman B; Sproul P
    Vaccine; 1986 Mar; 4(1):35-7. PubMed ID: 2421497
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterisation of a linear binding site for a monoclonal antibody to hepatitis B core antigen.
    Sällberg M; Rudén U; Magnius LO; Harthus HP; Noah M; Wahren B
    J Med Virol; 1991 Apr; 33(4):248-52. PubMed ID: 1713264
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Preclinical evaluation of two human anti-hepatitis B virus (HBV) monoclonal antibodies in the HBV-trimera mouse model and in HBV chronic carrier chimpanzees.
    Eren R; Ilan E; Nussbaum O; Lubin I; Terkieltaub D; Arazi Y; Ben-Moshe O; Kitchinzky A; Berr S; Gopher J; Zauberman A; Galun E; Shouval D; Daudi N; Eid A; Jurim O; Magnius LO; Hammas B; Reisner Y; Dagan S
    Hepatology; 2000 Sep; 32(3):588-96. PubMed ID: 10960454
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The prevalence of surface antigen variants of hepatitis B virus in Papua New Guinea, South Africa, and Sardinia.
    Carman WF; Van Deursen FJ; Mimms LT; Hardie D; Coppola R; Decker R; Sanders R
    Hepatology; 1997 Dec; 26(6):1658-66. PubMed ID: 9398013
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cell Attachment Domains of the Porcine Epidemic Diarrhea Virus Spike Protein Are Key Targets of Neutralizing Antibodies.
    Li C; Li W; Lucio de Esesarte E; Guo H; van den Elzen P; Aarts E; van den Born E; Rottier PJM; Bosch BJ
    J Virol; 2017 Jun; 91(12):. PubMed ID: 28381581
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epitopes associated with a synthetic hepatitis B surface antigen peptide.
    Ionescu-Matiu I; Kennedy RC; Sparrow JT; Culwell AR; Sanchez Y; Melnick JL; Dreesman GR
    J Immunol; 1983 Apr; 130(4):1947-52. PubMed ID: 6187828
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Generation and Characterization of a Neutralizing Human Monoclonal Antibody to Hepatitis B Virus PreS1 from a Phage-Displayed Human Synthetic Fab Library.
    Jo G; Jeong MS; Wi J; Kim DH; Kim S; Kim D; Yoon JY; Chae H; Kim KH; Hong HJ
    J Microbiol Biotechnol; 2018 Aug; 28(8):1376-1383. PubMed ID: 30301315
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A new vaccine escape mutant of hepatitis B virus causes occult infection.
    Ye Q; Shang SQ; Li W
    Hum Vaccin Immunother; 2015; 11(2):407-10. PubMed ID: 25692622
    [TBL] [Abstract][Full Text] [Related]  

  • 49. At least three epitopes are recognized by the human repertoire in the hepatitis B virus group a antigen inducing protection; possible consequences for seroprevention and serodiagnosis.
    Maillard P; Pillot J
    Res Virol; 1998; 149(3):153-61. PubMed ID: 9711539
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epitope-distal effects accompany the binding of two distinct antibodies to hepatitis B virus capsids.
    Bereszczak JZ; Rose RJ; van Duijn E; Watts NR; Wingfield PT; Steven AC; Heck AJ
    J Am Chem Soc; 2013 May; 135(17):6504-12. PubMed ID: 23597076
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hepatitis B virus core and e antigen: immune recognition and use as a vaccine carrier moiety.
    Schödel F; Peterson D; Milich D
    Intervirology; 1996; 39(1-2):104-10. PubMed ID: 8957676
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Establishment of monoclonal antibodies broadly neutralize infection of hepatitis B virus.
    Zhang H; Itoh Y; Suzuki T; Ihara KI; Tanaka T; Haga S; Enatsu H; Yumiya M; Kimura M; Takada A; Itoh D; Shibazaki Y; Nakao S; Yoshio S; Miyakawa K; Miyamoto Y; Sasaki H; Kajita T; Sugiyama M; Mizokami M; Tachibana T; Ryo A; Moriishi K; Miyoshi E; Kanto T; Okamoto T; Matsuura Y
    Microbiol Immunol; 2022 Apr; 66(4):179-192. PubMed ID: 35084739
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Wild-type and 'a' epitope variants in chronic hepatitis B virus carriers positive for hepatitis B surface antigen and antibody.
    Mesenas SJ; Chow WC; Zhao Y; Lim GK; Oon CJ; Ng HS
    J Gastroenterol Hepatol; 2002 Feb; 17(2):148-52. PubMed ID: 11966944
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fine mapping and functional characterization of two immuno-dominant regions from the preS2 sequence of hepatitis B virus.
    Meisel H; Sominskaya I; Pumpens P; Pushko P; Borisova G; Deepen R; Lu X; Spiller GH; Krüger DH; Grens E
    Intervirology; 1994; 37(6):330-9. PubMed ID: 8586531
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Discrimination of hepatitis B virus (HBV) subtypes using monoclonal antibodies to the PreS1 and PreS2 domains of the viral envelope.
    Mimms LT; Floreani M; Tyner J; Whitters E; Rosenlof R; Wray L; Goetze A; Sarin V; Eble K
    Virology; 1990 Jun; 176(2):604-19. PubMed ID: 1693248
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Analysis of the epitope and neutralizing capacity of human monoclonal antibodies induced by hepatitis B vaccine.
    Tajiri K; Ozawa T; Jin A; Tokimitsu Y; Minemura M; Kishi H; Sugiyama T; Muraguchi A
    Antiviral Res; 2010 Jul; 87(1):40-9. PubMed ID: 20412816
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multiple epitopes of hepatitis B virus surface antigen targeted by human plasma-derived immunoglobulins coincide with clinically observed escape mutations.
    Tarafdar S; Virata ML; Yan H; Zhong L; Deng L; Xu Y; He Y; Struble E; Zhang P
    J Med Virol; 2022 Feb; 94(2):649-658. PubMed ID: 34406663
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CD4+ T Cells Are Not Required for Suppression of Hepatitis B Virus Replication in the Liver of Vaccinated Chimpanzees.
    Rybczynska J; Campbell K; Kamili S; Locarnini S; Krawczynski K; Walker CM
    J Infect Dis; 2016 Jan; 213(1):49-56. PubMed ID: 26324781
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Protective effect of a synthetic peptide comprising the complete preS2 region of the hepatitis B virus surface protein.
    Emini EA; Larson V; Eichberg J; Conard P; Garsky VM; Lee DR; Ellis RW; Miller WJ; Anderson CA; Gerety RJ
    J Med Virol; 1989 May; 28(1):7-12. PubMed ID: 2723618
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A novel T-cell epitope in the transmembrane region of the hepatitis B virus envelope protein responds upon dendritic cell expansion.
    Chen L; Zhang Y; Zhang S; Chen Y; Shu X; Lai J; Cao H; Lian Y; Stamataki Z; Huang Y
    Arch Virol; 2019 Feb; 164(2):483-495. PubMed ID: 30415392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.